尿道阻塞和脱水导致尿道阻塞和脱水.

Same author

Distribution of gentamicin in body fluids.

British medical journal·2010

Same author

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Clinical endocrinology·1997

Same author

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

The Prostate·1996

Same author

Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Urological research·1996

Same author

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

European journal of cancer (Oxford, England : 1990)·1995

Same author

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy.

The Journal of urology·1995

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

尿道阻塞和脱水导致尿道阻塞和脱水.

相关概念视频

Distribution of gentamicin in body fluids.

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

尿道阻塞和脱水导致尿道阻塞和脱水.

相关概念视频

相关文章

Distribution of gentamicin in body fluids.

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.